Our team assesses biomarkers, goals, and designs protocolsNAD+ via injections/IVs, 5-Amino-1MQ as capsules/injections
Analiza Biaek Finished Product Verified Independent testing of the sealed vial by a leading EU laboratory Sample: Sealed production vial | Order: 100014035 | Tested: April 2026 | Verification Key: H4A29M5E Quanta Pharma 5-Amino-1MQ Specifications 5-Amino-1MQ 50mg by Quanta Pharma Quanta Pharma 5-Amino-1MQ Research Benefits NNMT inhibition : Selectively blocks nicotinamide N-methyltransferase, the enzyme responsible for degrading NAD+ precursors and SAM methyl donors Reduced adipogenesis : Preclinical research demonstrates significant reduction in fat cell formation and white adipose tissue accumulation NAD+ preservation : By inhibiting NNMT, cellular nicotinamide is conserved and available for NAD+ synthesis, supporting mitochondrial function Metabolic regulation : Investigated for effects on insulin sensitivity, glucose metabolism, and cellular energy expenditure Anti-obesity research : Studies in diet-induced obesity models have shown reductions in body weight and adipose mass without affecting food intake Orally bioavailable : As a small molecule rather than a peptide, it maintains activity via oral administration in research protocols, avoiding the need for injection How Quanta Pharma 5-Amino-1MQ Works 5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule selective inhibitor of nicotinamide N-methyltransferase, or NNMT
You may also combine AOD 9604 with tirzepatide in a weight loss program
These practices are experimental but based on GHK-Cus known ability to enhance collagen remodeling and reduce inflammation
doi:10.1136/bmjopen-2014-006964
